Heidelberg Pharma AG

Director's Dealing • Aug 6, 2010

News Details

Directors’ Dealings | 6 August 2010 15:39

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Krebs First name: Andreas R. Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: No par value bearer shares of common stock ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Purchase/Subscription Date: 05.08.2010 Price: 4.10 Currency: EUR No. of items: 10662 Total amount traded: 43714.20 Place: Außerbörslich/OTC Explanation for publication: Subscription and additional subscription Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 06.08.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ID 11718